UChicago Genetics in Clinical Cancer Care
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Healthy Lifestyle and Interventions to Reduce Stress in Cancer Prevention: Smoking Cessation, Physical Activity & Cancer-Related Distress
FEATURING
Yasmin Asvat
- 309 views
- February 16, 2021
- 1
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
POSH Study Data on Hereditary Genes & Outcome in Young-Onset BC: How Important Are BRCA1/2? What Is the Role of Other Genes? What Is Relation Between Prevention Timing Decisions and Primary Cancer Prognosis?
FEATURING
Diana Eccles
- 8 views
- February 16, 2021
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Disparities in Myeloma and Its Precursors in African Americans: Is Survival Equal in Whites and Blacks? What Can We Do to Reduce the Race Disparity?
FEATURING
Timothy Rebbeck
- 6 views
- February 16, 2021
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Polygenic Risk Scores in African American Populations: How Does PRS Perform in African American Women? Can Clinical Use of PRS Exacerbate BC Health Disparities?
FEATURING
Julie Palmer
- 9 views
- February 16, 2021
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Polygenic Risk of Breast Cancer in Latinx Populations: Is There Attenuation by Ancestry? Does PRS Work Well in Latinas? What Are the Intermediate Penetrance Genes?
FEATURING
Elad Ziv
- 6 views
- February 16, 2021
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Advances in Imaging Technologies and Artificial Intelligence for Early Detection of BC: Why Is Deep Learning a Significant Advance? What Are the Immediate Applications?
FEATURING
Robert Nishikawa
- 79 views
- February 16, 2021
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Genetic & Phenotypic Heterogeneity of Lynch Syndrome: How Was the Non-Polyposis Familial CRC Syndrome Solved? What Are the Clinical & Genetic Features? What Are the Implications for Hypermutated Cancer?
FEATURING
Richard Boland
- 17 views
- February 16, 2021
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
New Frontiers in Prevention & Early Detection of Cancer at the Population Level: Risk Behavior Modification, Chemoprevention Agents, Blood Based Screening, Detection & Surveillance Methods, Immuno-Prevention
FEATURING
Marcia Cruz Correa
- 8 views
- February 16, 2021
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Prostate Cancer, DNA Repair Pathways & Clinical Implications for Inherited Cancer Risk: What Is the Role of BRCA2? Can Screening Factor Potential for Progression to Metastatic Disease?
FEATURING
Heather Cheng
- 9 views
- February 16, 2021
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
23 y/o Male With Unilateral Retinoblastoma: Genetic Testing, Incidental Finding of BRCA1 Pathogenic Variant, Pros/Cons of Testing of Minors
FEATURING
Melody Perpich
- 5 views
- February 15, 2021
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Targeted Therapy for High-Risk Myeloid Malignancies: Aza+/-Ven in Older AML Disease, Aza/Dec for MDS, Ven+Aza in Treatment-Naïve MDS, Ena/Ivo for IDH-Mutated MPN
FEATURING
Olatoyosi Odenike
- 84 views
- February 15, 2021
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Somatic/Germline Cancer Genomics - Lessons Learned From Liquid Biopsies: What to Do When Specific Tumor Markers Are Not Available? How to Identify Germline Mutations?
- 6 views
- February 15, 2021
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Tumor Mutation Signatures (MSI/MMRd, HRD, POLE/POLD1, CDK12) in Cancer: What Is Their Correlation With Heritable Risk Factors & Targeted Therapy? Can They Help in Germline Cancer Workup?
FEATURING
Colin Pritchard
- 17 views
- February 15, 2021
UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Detecting Germline Mutations by Using Leukemia/Tumor Cells NGS Data: Diagnosis Opprotunity for HLA-Matched Related ASC Donors, Molecular Profiling, Identifying Somatic/Germline Variants
FEATURING
Lucy Godley
- 8 views
- February 15, 2021
